Literature DB >> 29655071

EEG gamma synchronization is associated with response to paroxetine treatment.

Mehmet Kemal Arikan1, Baris Metin2, Nevzat Tarhan1.   

Abstract

BACKGROUND: Resistance to medication is a significant problem in psychiatric practice, and effective methods for predicting response are needed to optimize treatment efficacy and limit morbidity. Gamma oscillations are considered as an index of the brain's general cognitive activity; however, the role of gamma oscillations in disease has not been studied sufficiently. AIM: This study aimed to determine if gamma power during rest can be used to predict response to anti-depressant medication treatment.
METHOD: Hamilton Depression Rating Scale (HDRS) score and resting state gamma power was measured in 18 medication-free patients during an episode of major depression. After 6 weeks of paroxetine monotherapy HDRS was administered again.
RESULTS: Baseline gamma power at frontal, central and temporal electrodes before treatment was significantly related to post-treatment change in HDRS scores.
CONCLUSION: The results indicate that gamma oscillations could be considered a marker of response to paroxetine treatment in patients with major depression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Paroxetine; Personalized medicine; Quantitative EEG; Treatment response

Mesh:

Substances:

Year:  2018        PMID: 29655071     DOI: 10.1016/j.jad.2018.04.041

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  12 in total

1.  Venlafaxine stimulates PNN proteolysis and MMP-9-dependent enhancement of gamma power; relevance to antidepressant efficacy.

Authors:  Seham Alaiyed; P Lorenzo Bozzelli; Adam Caccavano; Jian Young Wu; Katherine Conant
Journal:  J Neurochem       Date:  2019-02-20       Impact factor: 5.372

Review 2.  Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.

Authors:  Candace Jones; Charles B Nemeroff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Plasticity of synapses and reward circuit function in the genesis and treatment of depression.

Authors:  Scott M Thompson
Journal:  Neuropsychopharmacology       Date:  2022-09-03       Impact factor: 8.294

4.  Venlafaxine Stimulates an MMP-9-Dependent Increase in Excitatory/Inhibitory Balance in a Stress Model of Depression.

Authors:  Seham Alaiyed; Mondona McCann; Gouri Mahajan; Grazyna Rajkowska; Craig A Stockmeier; Kenneth J Kellar; Jian Young Wu; Katherine Conant
Journal:  J Neurosci       Date:  2020-04-08       Impact factor: 6.167

5.  Increased MMP-9 levels with strain-dependent stress resilience and tunnel handling in mice.

Authors:  Kate Kennedy-Wood; Christi Anne S Ng; Seham Alaiyed; Patricia L Foley; Katherine Conant
Journal:  Behav Brain Res       Date:  2021-04-06       Impact factor: 3.352

Review 6.  Neuromodulation of Gamma-Range Auditory Steady-State Responses: A Scoping Review of Brain Stimulation Studies.

Authors:  Inga Griskova-Bulanova; Kristina Sveistyte; Jovana Bjekic
Journal:  Front Syst Neurosci       Date:  2020-06-29

Review 7.  Hormonal regulation of circuit function: sex, systems and depression.

Authors:  Rachel-Karson Thériault; Melissa L Perreault
Journal:  Biol Sex Differ       Date:  2019-02-28       Impact factor: 5.027

Review 8.  Extracellular matrix remodeling with stress and depression: Studies in human, rodent and zebrafish models.

Authors:  Ismary Blanco; Katherine Conant
Journal:  Eur J Neurosci       Date:  2020-08-19       Impact factor: 3.698

Review 9.  QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response.

Authors:  Sermin Kesebir; Ahmet Yosmaoğlu
Journal:  Heliyon       Date:  2018-08-22

Review 10.  Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder.

Authors:  Seung-Gul Kang; Seo-Eun Cho
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.